Vogt T, Stolz W, Braun-Falco O, Kaudewitz P, Eckert F, Abmayr W, Dummer R, Burg G
Department of Dermatology, University of Munich, Germany.
Cancer. 1991 Sep 1;68(5):1095-100. doi: 10.1002/1097-0142(19910901)68:5<1095::aid-cncr2820680532>3.0.co;2-6.
The current classification of cutaneous malignant lymphomas (ML) into low-grade and high-grade lymphomas was found to be of limited reproducibility and permitted only a rough prediction about outcome. With this in mind, the relationship between nuclear DNA content and both prognosis and histologic grading according to the Kiel classification was evaluated on Feulgen-stained imprint specimens. In all, 49 cases of malignant non-Hodgkin's lymphoma, primary of the skin or with an involvement of the skin as one of the first symptoms, were studied using a computerized high-resolution image analysis system. The 2c deviation index (2cDI), which reflects the variation of the nuclear DNA values around the normal diploid peak, was found to be the best prognostically relevant criterion. Using the 2cDI, a significant discrimination (P less than 0.001 in the U test) between low-grade and high-grade ML was achieved. The prognostic benefit of the 2cDI was well documented by a significant inverse correlation between the 2cDI and the period of time until the patients progressed at least into one higher stage or died of lymphoma (r equals -0.63, P less than 0.05). In addition, the 2cDI enabled prognosis of the course of disease. In the group with low 2cDI values (2cDI, less than 0.5), no progression of the disease was observed after 1 year. In the groups presenting with a 2cDI between 0.5 and 1.0 and higher than 1.0, a progression was found in 57% and 64% of the cases studied, respectively. In conclusion, these measurements indicate that the determination of DNA distribution patterns in imprint specimens allows a precise and objective prognostic evaluation of cutaneous ML.
目前将皮肤恶性淋巴瘤(ML)分为低度和高度淋巴瘤的分类方法,其可重复性有限,只能对预后进行粗略预测。考虑到这一点,我们在福尔根染色的印片标本上评估了核DNA含量与根据基尔分类法的预后及组织学分级之间的关系。总共对49例恶性非霍奇金淋巴瘤进行了研究,这些病例原发于皮肤或以皮肤受累作为首发症状之一,使用计算机化高分辨率图像分析系统进行分析。发现反映正常二倍体峰值周围核DNA值变化的2c偏差指数(2cDI)是与预后最相关的最佳标准。使用2cDI,在低度和高度ML之间实现了显著区分(U检验中P小于0.001)。2cDI与患者进展至至少一个更高分期或死于淋巴瘤的时间之间存在显著负相关(r等于 -0.63,P小于0.05),充分证明了2cDI对预后的益处。此外,2cDI能够对疾病进程进行预后评估。在2cDI值较低(2cDI小于0.5)的组中,1年后未观察到疾病进展。在2cDI介于0.5和1.0之间以及高于1.0的组中,分别有57%和64%的研究病例出现了疾病进展。总之,这些测量结果表明,测定印片标本中的DNA分布模式能够对皮肤ML进行精确客观的预后评估。